That is essential, since the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be effective. To put it simply, we need to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (diplomatic relations). And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're created to do. This was a breakthrough nearly no one saw. However it's going to have profound ramifications for treating disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be a lot of investment opportunities in this space, too. Moving topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown top biotech 2020). That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it pulled back perhaps considerably prior to going greater - tech predictions. I have actually been covering bitcoin for a very long time now. One of the first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary suggestion, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were mostly informing readers. But that's not the huge question anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So think about that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. jeff brown latest prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are numerous great personal business on the verge of hitting the public markets And I've been working on a brand-new method for you to invest even prior to these companies go public.
This chance has actually been constructing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the details. Go right here to book your spot free of charge.
Emma Walsh here, handling editor of the Diary. Routine Diary readers understand that tech isn't our typical beat (jeff brown top stock pick 2021). And when it pertains to tech investing, we leave it to the professionals. Thankfully, we have numerous such specialists in our Rolodex. Our associate Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing specialists we understand (jeff brown genome sequencing stock). In fact, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and anticipate what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and far more. These trends are experiencing exponential growth and creating unbelievable opportunities for investors. I wish to ensure all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. democratic republic. However in spite of what many readers may think, this is a trend that's just starting. Although the COVID-19 pandemic interfered with supply chains in 2015, an outstanding 250 million 5G-enabled devices were still offered.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown prediction). Losing 2 months of manufacturing and sales truly affects the number of 5G devices are sold in the fiscal year. When you think about all of that, selling 250 million units is remarkable. More importantly, the delays triggered by the pandemic developed a heap of bottled-up demand. And that demand is now going to be pressed into 2021. In reality, I anticipate that more than 500 million 5G devices will be delivered in 2021 - jeff brown predictions for 2021. Which's not my only 5G forecast When I have actually discussed 5G in the past, I have actually described its 3 different phases.
In Stage Two, 5G devices go on sale. 5G phones and other products begin to reach consumers. And in Phase Three, 5G services start to be provided (jeff brown latest prediction). That's when we start to see applications working on 5G networks. Think of things like huge multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Phase 3 by this summer season. This starts something of a virtuous cycle: Many people don't truly appreciate the innovation. But they will care if there are interesting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being established. In truth, 5G is going to open up a suite of amazing applications: self-driving vehicles, the Web of Things, robotic surgery, and more. All of these innovations require 5G. The investment chances going forward will be huge. Stepping away from 5G, the next important innovation I visualize in 2021 is CRISPR hereditary modifying. CRISPR represents "clustered regularly interspaced brief palindromic repeat." It's a mouthful. However it is among the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software application.
The program can crash or not work properly. CRISPR uses a comparable concept but with our hereditary code. "Typos" in our genome can result in illness. CRISPR can correct these "typos." For years, CRISPR was mainly a niche technology that wasn't well comprehended. And throughout that time, there were truly only 3 business operating in this area. But things are changing. CRISPR is no longer just theoretical. We're seeing actual results. We're treating illness and seeing that this innovation just works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and delivering amazing returns. This whole industry is efficiently a greenfield opportunity.
There's space for numerous business to exist in this space. longtime readers. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or 3 more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its most current Alpha, Fold software application can precisely predict the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That is very important because the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and be reliable.
Historically, this has been an experimental procedure. Today, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're developed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but a number of drug treatments produced utilizing this innovation. This was one of those breakthroughs that nearly nobody discovered. But it's going to have extensive ramifications for curing disease. And, of course, there will be plenty of financial investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it pulled back perhaps considerably prior to going higher. I have actually been covering bitcoin for a long time now. One of the first research study reports I ever released was on bitcoin - self-driving cars. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anybody who followed my suggestion. However at the time of that preliminary recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. jeff bezos. Mass, Mutual is a 150-year-old institution. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the information is up to date as of February 2021, however we could not independently confirm this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an exact figure at this moment. Brown is best understood for his sage-like ability to select winning technology stocks. He spent more than 25 years investigating technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an exceptional perspective on the marketplace. He's constantly on the hunt for new opportunities, and he shares much of his best choices in the Near Future Report.
That's full marks, however it's not absurdly reasoned. Brown has an excellent track record as a stock-picker, and he effectively anticipated some of the most significant economic events of the previous twenty years. Although he does not appear to release his choices to the public, the service's success is a direct sign of Brown's stock-picking prowess. Nobody on Wall Street gets it right each time, however Jeff Brown's accurate forecasts have made him legions of devoted fans. That states a lot about his ability. The Future Report is published by Brownstone Research, a popular financial research publisher. Brownstone Research study provides several research services with a variety of specializations - self-driving cars.
The business is likewise affiliated with Bonner & Partners, another well-respected research study publisher - jeff brown biotech genome sequencing. On its site, Brownstone states its mission is to provide retail investors with professional-grade research: "For too long, the very best financial investment research study has not been readily available to specific investors. It has actually been generally booked for investment banks, hedge funds, private equity, and high-net-worth customers. tech stocks. The mission of Brownstone Research study is to make that type of proprietary research available to any financiers wanting to gain an edge in the markets. The goal is basic to deliver unique and rewarding investment research discovered nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research, and he likewise functions as the company's Chief Financial investment Expert.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After decades of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a home name throughout many of America. If you know even a bit about the market, you understand that he has a credibility as a King Midas of sorts. biotech stocks. Everything he touches turns to gold! Jeff is well conscious of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge project.
In fact, Brown believes S.A.V. jeff brown 2021 stock picks. might be "the most significant trend of the 2020s, and he's not alone. Check out these quotes from other well-known S.A.V. bulls: Elon's next huge act will be marrying two innovative innovations: expert system and electric cars. Musk hopes the mix will assist him establish the first fully-autonomous, self-driving automobiles ever. It's nothing brief of the automobile industry's Holy Grail. As you know, electric vehicles and self-driving vehicle stocks have been substantial this year, however the Wall Street maker has approved buzz without much tangible result. Regardless of an extreme boost in competitors over the previous couple of years, Brown still thinks Musk has the finest chance of putting everything together.
tech could be the magic string that ties all of it together. S.A.V. stands for Shared Autonomous Lorry, and it might be the future of transport. Essentially, this technology would enable you to lease your automobile as a self-governing, self-driving taxi when you're not utilizing it. You just leave the automobile and press a button on an app that informs the car to "sign up with the fleet." Next thing you understand, you're relaxing on your couch while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a large piece of the revenues. It sounds outrageous, but it might be closed than you think.